Evidence map›Paper›PMID 34132750›Full record

ArticleJAMA psychiatry2021

Association of Cannabis Use During Adolescence With Neurodevelopment.

Matthew D Albaugh, Jonatan Ottino-Gonzalez, Amanda Sidwell, Claude Lepage, Anthony Juliano, Max M Owens, Bader Chaarani, Philip Spechler, Nicholas Fontaine, Pierre Rioux and 30 more

Open access · hybridAbstract read
In one paragraph

Article in JAMA psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Psychological Interventions for Cannabis Use among Adolescents and Young Adults: A Systematic Review.International journal of environmental research and public health · 2023
    Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Preliminary effectiveness of theInternet interventions · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Independent brain cortical signatures of risk for adolescent cannabis use and consequences of such use are moderated by sex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Research Review: What we have learned about the endocannabinoid system in developmental psychopathology.Journal of child psychology and psychiatry, and allied disciplines · 2025
    Review
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors at 19 institutions in 7 countries.

Matthew D AlbaughDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington.
Jonatan Ottino-GonzalezDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington.
Amanda SidwellDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington.
Claude LepageMcConnell Brain Imaging Centre, McGill University, Montreal, Quebec, Canada.
Anthony JulianoDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington.
Max M OwensDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington.
Bader ChaaraniDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington.
Philip SpechlerDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington.
Nicholas FontaineDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington.
Pierre RiouxMcConnell Brain Imaging Centre, McGill University, Montreal, Quebec, Canada.
Lindsay LewisMcConnell Brain Imaging Centre, McGill University, Montreal, Quebec, Canada.
Seun JeonMcConnell Brain Imaging Centre, McGill University, Montreal, Quebec, Canada.
Alan EvansMcConnell Brain Imaging Centre, McGill University, Montreal, Quebec, Canada.
Deepak D'SouzaDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
Rajiv RadhakrishnanDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Arun L W BokdeDiscipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
Erin Burke QuinlanCentre for Population Neuroscience and Precision Medicine, Institute of Psychiatry, Psychology, and Neuroscience, Social, Genetic & Developmental Psychiatry Centre, King's College London, London, United Kingdom.
Patricia ConrodDepartment of Psychiatry, University of Montreal, Montreal, Quebec, Canada.
Sylvane DesrivièresCentre for Population Neuroscience and Precision Medicine, Institute of Psychiatry, Psychology, and Neuroscience, Social, Genetic & Developmental Psychiatry Centre, King's College London, London, United Kingdom.
Herta FlorInstitute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Antoine GrigisNeuroSpin, Commissariat à l'Energie Atomique, Université Paris-Saclay, Gif-sur-Yvette, France.
Penny GowlandSir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, United Kingdom.
Andreas HeinzDepartment of Psychiatry and Psychotherapy Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Bernd IttermannPhysikalisch-Technische Bundesanstalt, Berlin, Germany.
Jean-Luc MartinotInstitut National de la Santé et de la Recherche Médicale U A10 "Trajectoires développementales en psychiatrie" Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France.
Marie-Laure Paillère MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM U A10 "Trajectoires développementales en psychiatrie," Paris, France.
Frauke NeesDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Dimitri Papadopoulos OrfanosNeuroSpin, Commissariat à l'Energie Atomique, Université Paris-Saclay, Gif-sur-Yvette, France.
Tomáš PausBloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada.
Luise PoustkaDepartment of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, Göttingen, Germany.
Sabina MillenetDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Juliane H FröhnerDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
Michael N SmolkaDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.
Henrik WalterDepartment of Psychiatry and Psychotherapy Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Robert WhelanSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.
Gunter SchumannCentre for Population Neuroscience and Precision Medicine, Institute of Psychiatry, Psychology, and Neuroscience, Social, Genetic & Developmental Psychiatry Centre, King's College London, London, United Kingdom.
Alexandra PotterDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington.
Hugh GaravanDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington.
IMAGEN Consortium
University of Vermont · USMcGill Genome Centre · CAHeidelberg University · DEFreie Universität Berlin · DEKing's College London · GBTrinity College Dublin · IETU Dresden · DEYale University · USCharité - Universitätsmedizin Berlin · DECommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRÉcole Normale Supérieure - PSL · FRKiel University · DEMcGill University · CAPhysikalisch-Technische Bundesanstalt · DEPitié-Salpêtrière Hospital · FRUniversité de Montréal · CAUniversité Paris-Saclay · FRUniversity of Nottingham · GBUniversity of Toronto · CA

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Training in Complex Systems and Data Science Approaches Applied to the Neurobiology of Drug UseT32DA043593 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI DODDS, PETER S., GARAVAN, HUGH P. · 2018 to 2022
$1.2M
Development and clinical validation of multimodal risk algorithms for predicting future internalizing psychopathologyK08MH121654 · NIMH · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI ALBAUGH, MATTHEW D · 2020 to 2023
$737k
Medical Research Council MR/N000390/1Medical Research Council MR/R00465X/1Medical Research Council MR/S020306/1MRF_ MRF-058-0004-RG-DESRIMRF_ MRF-058-0009-RG-DESR-C0759NCATS NIH HHS UL1 TR001863NIDA NIH HHS T32 DA043593NIMH NIH HHS K08 MH121654
6 · The paper itself

Abstract

importanceAnimal studies have shown that the adolescent brain is sensitive to disruptions in endocannabinoid signaling, resulting in altered neurodevelopment and lasting behavioral effects. However, few studies have investigated ties between cannabis use and adolescent brain development in humans.

objectiveTo examine the degree to which magnetic resonance (MR) imaging-assessed cerebral cortical thickness development is associated with cannabis use in a longitudinal sample of adolescents. DESIGN, SETTING, AND

participantsData were obtained from the community-based IMAGEN cohort study, conducted across 8 European sites. Baseline data used in the present study were acquired from March 1, 2008, to December 31, 2011, and follow-up data were acquired from January 1, 2013, to December 31, 2016. A total of 799 IMAGEN participants were identified who reported being cannabis naive at study baseline and had behavioral and neuroimaging data available at baseline and 5-year follow-up. Statistical analysis was performed from October 1, 2019, to August 31, 2020. MAIN OUTCOMES AND MEASURES: Cannabis use was assessed at baseline and 5-year follow-up with the European School Survey Project on Alcohol and Other Drugs. Anatomical MR images were acquired with a 3-dimensional T1-weighted magnetization prepared gradient echo sequence. Quality-controlled native MR images were processed through the CIVET pipeline, version 2.1.0.

resultsThe study evaluated 1598 MR images from 799 participants (450 female participants [56.3%]; mean [SD] age, 14.4 [0.4] years at baseline and 19.0 [0.7] years at follow-up). At 5-year follow-up, cannabis use (from 0 to >40 uses) was negatively associated with thickness in left prefrontal (peak: t785 = -4.87, cluster size = 1558 vertices; P = 1.10 × 10-6, random field theory cluster corrected) and right prefrontal (peak: t785 = -4.27, cluster size = 1551 vertices; P = 2.81 × 10-5, random field theory cluster corrected) cortices. There were no significant associations between lifetime cannabis use at 5-year follow-up and baseline cortical thickness, suggesting that the observed neuroanatomical differences did not precede initiation of cannabis use. Longitudinal analysis revealed that age-related cortical thinning was qualified by cannabis use in a dose-dependent fashion such that greater use, from baseline to follow-up, was associated with increased thinning in left prefrontal (peak: t815.27 = -4.24, cluster size = 3643 vertices; P = 2.28 × 10-8, random field theory cluster corrected) and right prefrontal (peak: t813.30 = -4.71, cluster size = 2675 vertices; P = 3.72 × 10-8, random field theory cluster corrected) cortices. The spatial pattern of cannabis-related thinning was associated with age-related thinning in this sample (r = 0.540; P < .001), and a positron emission tomography-assessed cannabinoid 1 receptor-binding map derived from a separate sample of participants (r = -0.189; P < .001). Analysis revealed that thinning in right prefrontal cortices, from baseline to follow-up, was associated with attentional impulsiveness at follow-up. CONCLUSIONS AND RELEVANCE: Results suggest that cannabis use during adolescence is associated with altered neurodevelopment, particularly in cortices rich in cannabinoid 1 receptors and undergoing the greatest age-related thickness change in middle to late adolescence.

Identifiers

PMID34132750
PMCPMC8209561
OpenAlexW3167787546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.